Free Trial

CompoSecure, Inc. (NASDAQ:CMPO) Insider Adam Joseph Lowe Sells 18,818 Shares

CompoSecure logo with Business Services background
Remove Ads

CompoSecure, Inc. (NASDAQ:CMPO - Get Free Report) insider Adam Joseph Lowe sold 18,818 shares of CompoSecure stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $10.97, for a total transaction of $206,433.46. Following the completion of the transaction, the insider now directly owns 1,486,036 shares of the company's stock, valued at $16,301,814.92. This trade represents a 1.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.

CompoSecure Trading Up 6.1 %

CompoSecure stock traded up $0.63 during midday trading on Friday, reaching $11.02. 1,070,143 shares of the stock traded hands, compared to its average volume of 754,900. The firm has a fifty day moving average price of $14.52 and a two-hundred day moving average price of $14.53. The firm has a market cap of $1.13 billion, a price-to-earnings ratio of -25.05, a PEG ratio of 2.63 and a beta of 0.77. CompoSecure, Inc. has a fifty-two week low of $5.58 and a fifty-two week high of $17.71.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of CMPO. Principal Financial Group Inc. acquired a new position in CompoSecure during the 3rd quarter valued at about $146,000. Wolverine Asset Management LLC bought a new stake in shares of CompoSecure during the 3rd quarter worth about $74,000. Bard Associates Inc. raised its position in shares of CompoSecure by 0.6% during the 3rd quarter. Bard Associates Inc. now owns 305,247 shares of the company's stock worth $4,280,000 after buying an additional 1,957 shares in the last quarter. Islay Capital Management LLC bought a new stake in shares of CompoSecure during the 3rd quarter worth about $633,000. Finally, Charles Schwab Investment Management Inc. raised its position in shares of CompoSecure by 46.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 69,162 shares of the company's stock worth $970,000 after buying an additional 21,793 shares in the last quarter. 37.56% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. TD Cowen assumed coverage on shares of CompoSecure in a report on Wednesday, December 18th. They issued a "buy" rating and a $20.00 price target for the company. JPMorgan Chase & Co. decreased their price target on shares of CompoSecure from $16.00 to $15.00 and set a "neutral" rating for the company in a report on Thursday, March 6th. Lake Street Capital decreased their price target on shares of CompoSecure from $18.00 to $15.00 and set a "buy" rating for the company in a report on Thursday, March 6th. Finally, Needham & Company LLC decreased their price target on shares of CompoSecure from $16.00 to $15.00 and set a "buy" rating for the company in a report on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, CompoSecure presently has an average rating of "Moderate Buy" and an average target price of $16.19.

Remove Ads

Get Our Latest Research Report on CompoSecure

About CompoSecure

(Get Free Report)

CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.

Read More

Insider Buying and Selling by Quarter for CompoSecure (NASDAQ:CMPO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CompoSecure Right Now?

Before you consider CompoSecure, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CompoSecure wasn't on the list.

While CompoSecure currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Institutions Are Dumping These 3 Stocks—Should You?
Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads